Kensei Tobinai, MD,PhD
National Cancer Center Hospital
2
2
2
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Beata Holkova, MD
Massey Cancer Center
Shared therapeutic areas:
Eliot Epner, MD
Penn State Hershey Cancer Institute
Shared therapeutic areas:
Maria Delioukina, MD
City of Hope National Medical Center, USA
Shared therapeutic areas:
Peter Brown, MD
H:S Rigshospitalet, Department of Hematology, Denmark
Shared therapeutic areas:
Madeleine Duvic, MD
UT - M. D. Anderson Cancer Center
Shared therapeutic areas:
Fernando Camacho, MD
Bronx River Medical Associates, PC
Shared therapeutic areas:
Andrei Shustov, MD
Fred Hutchinson Cancer Research Center - Seattle Cancer Care Alliance
Shared therapeutic areas:
Andreas Neubauer, MD
University Hospital Marburg, Marburg, Germany
Shared therapeutic areas:
Adam Lerner, MD
Boston Medical Center, USA
Shared therapeutic areas:
Amanda Cashen, MD
Wasington University School of Medicine- Division of Oncology
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Phase I/II Clinical Study of Pralatrexate in Japanese Patients With Relapsed or Refractory Peripheral T-cell Lymphoma
Phase I/II Clinical Study of Forodesine in Japanese Recurrent/Refractory Peripheral T-cell Lymphoma Patients
All 2 trials loaded